SPOTLIGHT -
Following TBI, cognitive deficits, comorbid medical and neurological problems, as well as complex pharmacotherapeutic needs and sensitivities frequently complicate evaluation and treatment of psychosis in this population.
The Week in Review: April 15-19
Treating ‘Morally Objectionable’ Patients
Management of Borderline Personality Disorder in an Obstetric Unit
What Will the Future of Alzheimer Disease Treatment Look Like?
New Data Demonstrates KarXT’s Positive Long-Term Metabolic Profile
Schizophrenia Research Roundup: April 12, 2024